Leonteq Securities’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Leonteq Securities's VKTX Position: Q3 2026 in Review
Leonteq Securities increased its Viking Therapeutics (VKTX) stake by 76% in Q3 2026, buying an estimated $408K and bringing the position to 27,232 shares worth $888K. The position accounts for 0.04% of the portfolio, ranked #251.
Leonteq Securities first reported a position in VKTX in Q4 2023 and has held it in 12 quarters since. 444 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.
- Leonteq Securities held 27,232 shares of Viking Therapeutics worth $888K as of Q3 2026.
- Leonteq Securities bought 11,775 Viking Therapeutics shares in Q3 2026, an estimated $408K.
- Viking Therapeutics made up 0.04% of Leonteq Securities's portfolio in Q3 2026, its #251 holding.
- Leonteq Securities first reported a position in Viking Therapeutics in Q4 2023 and has held it in 12 quarters since.
- 444 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.